Eugenie S. Kleinerman

11.1k total citations · 2 hit papers
212 papers, 7.9k citations indexed

About

Eugenie S. Kleinerman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eugenie S. Kleinerman has authored 212 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 80 papers in Oncology and 63 papers in Immunology. Recurrent topics in Eugenie S. Kleinerman's work include Sarcoma Diagnosis and Treatment (52 papers), RNA Interference and Gene Delivery (33 papers) and Immunotherapy and Immune Responses (26 papers). Eugenie S. Kleinerman is often cited by papers focused on Sarcoma Diagnosis and Treatment (52 papers), RNA Interference and Gene Delivery (33 papers) and Immunotherapy and Immune Responses (26 papers). Eugenie S. Kleinerman collaborates with scholars based in United States, Japan and Australia. Eugenie S. Kleinerman's co-authors include Zhichao Zhou, Isaiah J. Fidler, Shu-Fang Jia, Laura L. Worth, Nancy Gordon, Nadezhda V. Koshkina, Brock A. Lindsey, Justin Markel, Hui Guan and Xiaoping Duan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Eugenie S. Kleinerman

212 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

2008 520 citations Paul A. Meyers, Cindy L. Schwartz et al. Journal of Clinical Oncology profile →
Osteosarcoma Overview

2016 344 citations Eugenie S. Kleinerman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Eugenie S. Kleinerman	3.2k	2.8k	2.4k	2.4k	1.3k	212	7.9k
Saburo Sone	3.5k 1.1×	2.8k 1.0×	2.2k 0.9×	2.2k 0.9×	1.1k 0.8×	259	8.2k
Arun Seth	4.5k 1.4×	1.8k 0.6×	1.6k 0.7×	813 0.3×	1.7k 1.4×	187	8.1k
Chand Khanna	3.4k 1.1×	2.3k 0.8×	2.8k 1.2×	1.1k 0.5×	1.4k 1.1×	126	7.8k
Jerry S. Lanchbury	2.3k 0.7×	2.0k 0.7×	1.8k 0.7×	2.0k 0.8×	1.4k 1.1×	163	7.7k
Jared Gollob	3.3k 1.0×	1.6k 0.6×	1.2k 0.5×	1.6k 0.7×	912 0.7×	107	6.3k
Bharat Jasani	3.1k 1.0×	2.6k 0.9×	1.0k 0.4×	981 0.4×	1.3k 1.1×	225	7.9k
Peter J. Nelson	4.8k 1.5×	3.9k 1.4×	1.1k 0.5×	4.6k 2.0×	1.7k 1.3×	252	13.8k
Mark Brantly	3.0k 0.9×	2.5k 0.9×	2.0k 0.8×	706 0.3×	3.0k 2.4×	187	8.7k
Robert Hromas	6.1k 1.9×	2.7k 1.0×	773 0.3×	2.7k 1.1×	969 0.8×	207	10.4k
Claire Danel	2.2k 0.7×	1.9k 0.7×	3.1k 1.3×	1.4k 0.6×	465 0.4×	171	7.5k

Countries citing papers authored by Eugenie S. Kleinerman

Since Specialization

Citations

This map shows the geographic impact of Eugenie S. Kleinerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenie S. Kleinerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenie S. Kleinerman more than expected).

Fields of papers citing papers by Eugenie S. Kleinerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugenie S. Kleinerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenie S. Kleinerman. The network helps show where Eugenie S. Kleinerman may publish in the future.

Co-authorship network of co-authors of Eugenie S. Kleinerman

This figure shows the co-authorship network connecting the top 25 collaborators of Eugenie S. Kleinerman. A scholar is included among the top collaborators of Eugenie S. Kleinerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenie S. Kleinerman. Eugenie S. Kleinerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yifan, et al.. (2024). CD103+ cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases. Cancers. 16(19). 3251–3251. 4 indexed citations

Jeyabal, Prince, Anchit Bhagat, Fei Wang, et al.. (2023). Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clinical Cancer Research. 29(21). 4430–4440. 6 indexed citations

Ma, Huaxian, Mansour Alfayez, Fei Wang, et al.. (2023). Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. Blood Advances. 7(21). 6624–6629. 2 indexed citations

Zhou, Yifan, Oleksandr Kyrysyuk, Yusra B. Medik, et al.. (2020). Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103⁺ conventional dendritic cells. Journal for ImmunoTherapy of Cancer. 8(1). e000474–e000474. 84 indexed citations

Subbiah, Vivek, Pete Anderson, Kalevi Kairemo, et al.. (2019). Alpha Particle Radium 223 Dichloride in High-risk Osteosarcoma: A Phase I Dose Escalation Trial. Clinical Cancer Research. 25(13). 3802–3810. 32 indexed citations

Livingston, J. Andrew, Wei‐Lien Wang, Jen-Wei Tsai, et al.. (2018). Analysis of HSP27 and the Autophagy Marker LC3B+ Puncta Following Preoperative Chemotherapy Identifies High-Risk Osteosarcoma Patients. Molecular Cancer Therapeutics. 17(6). 1315–1323. 15 indexed citations

Yang, Yuanzheng, Gangxiong Huang, Zhichao Zhou, Jason G. Fewell, & Eugenie S. Kleinerman. (2017). miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases. Molecular Cancer Therapeutics. 17(1). 130–139. 12 indexed citations

Hu, Jiemiao, Chantale Bernatchez, Liangfang Zhang, et al.. (2017). Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8+ T Cells and Histone Acetyltransferases. Cancer Immunology Research. 5(4). 300–311. 21 indexed citations

Dibra, Denada, Abhisek Mitra, Xueqing Xia, et al.. (2016). Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo. Clinical Cancer Research. 22(15). 3876–3883. 12 indexed citations

10.

Satelli, Arun, Abhisek Mitra, Jeffry J. Cutrera, et al.. (2014). Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells. Cancer Research. 74(6). 1645–1650. 131 indexed citations

11.

Hamdan, Randala, Zhichao Zhou, & Eugenie S. Kleinerman. (2013). Blocking SDF-1α/CXCR4 Downregulates PDGF-B and Inhibits Bone Marrow–Derived Pericyte Differentiation and Tumor Vascular Expansion in Ewing Tumors. Molecular Cancer Therapeutics. 13(2). 483–491. 32 indexed citations

12.

Hamdan, Randala, Zhichao Zhou, & Eugenie S. Kleinerman. (2011). SDF-1α Induces PDGF-B Expression and the Differentiation of Bone Marrow Cells into Pericytes. Molecular Cancer Research. 9(11). 1462–1470. 28 indexed citations

13.

Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638. 520 indexed citations breakdown →

14.

Zhou, Zhichao, et al.. (2007). EWS/FLI1 Regulates Tumor Angiogenesis in Ewing's Sarcoma via Suppression of Thrombospondins. Cancer Research. 67(14). 6675–6684. 32 indexed citations

15.

Yu, Ling, Xiaofang Wang, Robert R. Langley, et al.. (2006). The role of MEKK3 in osteosarcoma invasion and metastasis. Cancer Research. 66. 429–429. 1 indexed citations

16.

Asano, Takeshi, Eugenie S. Kleinerman, Leonard A. Zwelling, Zhichao Zhou, & Yoshitaka Fukunaga. (2005). Adenovirus-mediated human topoisomerase IIα gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells. Acta Oncologica. 44(3). 240–247. 11 indexed citations

17.

Koshkina, Nadezhda V., et al.. (2000). 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.. PubMed. 6(7). 2876–80. 85 indexed citations

18.

Kleinerman, Eugenie S. & N Jaffe. (1991). Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of osteosarcoma. 43(2). 127–132. 1 indexed citations

19.

Kleinerman, Eugenie S., et al.. (1988). Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.. PubMed. 48(9). 2604–9. 37 indexed citations

20.

Kleinerman, Eugenie S., Charles A. Daniels, Yue Li, & Ralph Snyderman. (1976). Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 85(2). 373–82. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact